137 related articles for article (PubMed ID: 8470423)
41. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
[TBL] [Abstract][Full Text] [Related]
42. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
[TBL] [Abstract][Full Text] [Related]
43. Comparison of a rapid hepatitis B immunization schedule to the standard schedule for adults.
Marsano LS; Greenberg RN; Kirkpatrick RB; Zetterman RK; Christiansen A; Smith DJ; DeMedina MD; Schiff ER
Am J Gastroenterol; 1996 Jan; 91(1):111-5. PubMed ID: 8561109
[TBL] [Abstract][Full Text] [Related]
44. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
[TBL] [Abstract][Full Text] [Related]
45. Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China.
Zhang L; Liu J; Lu J; Yan B; Song L; Li L; Cui F; Zhang G; Wang F; Liang X; Xu A
Hum Vaccin Immunother; 2015; 11(11):2716-22. PubMed ID: 26252481
[TBL] [Abstract][Full Text] [Related]
46. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298
[TBL] [Abstract][Full Text] [Related]
47. Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life.
Freitas da Motta MS; Mussi-Pinhata MM; Jorge SM; Tachibana Yoshida CF; Sandoval de Souza CB
Vaccine; 2002 Feb; 20(11-12):1557-62. PubMed ID: 11858862
[TBL] [Abstract][Full Text] [Related]
48. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664
[TBL] [Abstract][Full Text] [Related]
49. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose.
Wiström J; Ahlm C; Lundberg S; Settergren B; Tärnvik A
Vaccine; 1999 Apr; 17(17):2162-5. PubMed ID: 10367949
[TBL] [Abstract][Full Text] [Related]
50. Seroconversion with rDNA hepatitis B vaccine of Cuban origin.
Kar P; Jandwani P; Khurana V; Kumar V; Gupta RK; Sama S; Wadhawan S
Indian J Gastroenterol; 1997 Oct; 16(4):161. PubMed ID: 9357198
[No Abstract] [Full Text] [Related]
51. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine.
Zhang W; Han L; Lin C; Wang H; Pang X; Li L; Gao P; Lin H; Gong X; Tang Y; Ma J; Zhang H; Wang C; Yang P; Li H; Sun M; He X
Vaccine; 2011 Aug; 29(37):6276-82. PubMed ID: 21722684
[TBL] [Abstract][Full Text] [Related]
52. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
53. The persistence of anti-hepatitis B surface antibodies to three years of age: is a hepatitis B vaccine booster required?
Gunn TR; Woodfield DG
N Z Med J; 1993 Nov; 106(968):499-501. PubMed ID: 8247433
[TBL] [Abstract][Full Text] [Related]
54. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.
Yao J; Ren J; Shen L; Chen Y; Liang X; Cui F; Li Q; Jiang Z; Wang F
Hum Vaccin; 2011 Oct; 7(10):1055-9. PubMed ID: 21989290
[TBL] [Abstract][Full Text] [Related]
55. Seroprotection after hepatitis B vaccination in chronic kidney disease patients with modified schedule and dosage.
Siddiqui S; Malik A; Shukla I; Rizvi M; Haque SF
J Infect Dev Ctries; 2010 Jun; 4(6):389-92. PubMed ID: 20601791
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the immunogenicity of a recombinant vaccine against hepatitis B containing S and pre-S2 sequences using two different schedules.
Gizaris V; Roumeliotou A; Ktenas E; Papoutsakis G; Papaevangelou G
Vaccine; 1993 Nov; 11(14):1445-7. PubMed ID: 8310765
[TBL] [Abstract][Full Text] [Related]
57. Immune response after vaccination with recombinant hepatitis surface antigen in maintenance hemodialysis patients and healthy controls.
Allegra V; Vasile A; Maschio M; Mengozzi G
Nephron; 1992; 61(3):339-40. PubMed ID: 1386908
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis B virus vaccination for older adults.
Bennett RG; Powers DC; Remsburg RE; Scheve A; Clements ML
J Am Geriatr Soc; 1996 Jun; 44(6):699-703. PubMed ID: 8642163
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa Gene 3 containing pre-S1, pre-S2, and S gene products.
Wagner D; Wagenbreth I; Stachan-Kunstyr R; Thoma HA; Hemmerling AE; Flik J
Clin Investig; 1994 May; 72(5):350-2. PubMed ID: 8086768
[TBL] [Abstract][Full Text] [Related]
60. Immunogenicity of a recombinant hepatitis B vaccine in hemodialysis patients: a two-year follow-up.
Docci D; Cipolloni PA; Mengozzi S; Baldrati L; Capponcini C; Feletti C
Nephron; 1992; 61(3):352-3. PubMed ID: 1386909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
